Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects

University of North Carolina at Chapel Hill, Chapel Hill

Duke University Medical Center, Durham

AHF Research, Los Angeles

Harbor UCLA, Research & Education Institute, Torrance

Pacific Horizon Medical Group, San Francisco

Stephen Becker, MD, San Francisco

Community Research Initiative of New England, Boston

Community Research Initiative of New England, Springfield

The University of North Carolina at Chapel Hill, Chapel Hill

University of Ottawa at the Ottawa Health Research Institute, Ottawa

University of Ottawa Health Research Institute, Ottawa